Source:http://linkedlifedata.com/resource/pubmed/id/21328310
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2011-4-26
|
pubmed:abstractText |
GSK3? plays an important role in many physiological functions; dysregulated GSK3? is involved in human diseases such as diabetes, cancer, and Alzheimer's disease. This study uses MD simulations to determine the interaction between GSK3? and a peptide derived from GSKIP, a novel GSK3? interacting protein. Results show that GSKIPtide is inlaid in a binding pocket consisting of an ?-helix and an extended loop near the carboxy-terminal end. This binding pocket is hydrophobic, and is responsible for the protein-protein interaction of two other GSK3? interacting proteins: FRAT and Axin. The GSKIPtide binding mode is closer to that of AxinGID (in the Axin-GSK3-interacting domain). The single-point mutations of V267G and Y288F in GSK3? differentiate the binding modes between GSK3 and GSKIPtide, AxinGID, and FRATide. The V2677G mutation of GSK3? reduces the GSKIPtide binding affinity by 70% and abolishes the binding affinity with AxinGID, but has no effect on FRATide. However, GSK3? Y288F completely abolishes the FRATide binding without affecting GSKIPtide or AxinGID binding. An analysis of the GSK3?-GSKIPtide complex structure and the X-ray crystal structures of GSK3?-FRATide and GSK3?-AxinGID complexes suggests that the hydroxyl group of Y288 is crucial to maintaining a hydrogen bond network in GSK3?-FRATide. The hydrophobic side chain of V267 maintains the integrity of helix-helix ridge-groove hydrophobic interaction for GSK3?-GSKIPtide and GSK3?-AxinGID. This study simulates these two mutant systems to provide atomic-level evidence of the aforementioned experimental results and validate the wild-type complex structure prediction.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C14orf129 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Glycogen Synthase Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/glycogen synthase kinase 3 beta
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-3525
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Wiley Periodicals, Inc., a Wiley company.
|
pubmed:issnType |
Print
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
461-71
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:21328310-Amino Acid Sequence,
pubmed-meshheading:21328310-Glycogen Synthase Kinase 3,
pubmed-meshheading:21328310-Humans,
pubmed-meshheading:21328310-Molecular Dynamics Simulation,
pubmed-meshheading:21328310-Molecular Sequence Data,
pubmed-meshheading:21328310-Protein Conformation,
pubmed-meshheading:21328310-Repressor Proteins,
pubmed-meshheading:21328310-Static Electricity
|
pubmed:year |
2011
|
pubmed:articleTitle |
Prediction of the binding mode between GSK3? and a peptide derived from GSKIP using molecular dynamics simulation.
|
pubmed:affiliation |
Department of Internal Medicine, Zuoying Armed Forces General Hospital, Kaohsiung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|